<DOC>
	<DOCNO>NCT01559116</DOCNO>
	<brief_summary>The primary objective trial determine 24-hour FEV1-time profile tiotropium + olodaterol FDC , administer daily RESPIMAT Inhaler 6 week treatment .</brief_summary>
	<brief_title>Characterization 24-hour Lung Function Profiles Inhaled Tiotropium + Olodaterol Fixed Dose Combination Patients Suffering From Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Diagnosis chronic obstructive pulmonary disease 2 . Relatively stable airway obstruction postbronchodilator FEV1 &lt; 80 % predict normal postbronchodilator FEV1/FVC &lt; 70 % 3 . Male female patient , 40 year age old 4 . Smoking history 10 pack year 5 . Ability perform technically acceptable pulmonary function test maintain record 6 . Ability inhale medication competent manner RESPIMAT Inhaler meter dose inhaler ( MDI ) Exclusion criterion : 1. significant disease COPD 2. clinically relevant abnormal lab value 3. history asthma 4. diagnosis thyrotoxicosis 5. diagnosis paroxysmal tachycardia 6. history myocardial infarction 7. unstable lifethreatening cardiac arrhythmia 8 . Hospitalization heart failure within past year 9. know active tuberculosis 10. malignancy patient undergone resection , radiation therapy chemotherapy within last five year 11. history lifethreatening pulmonary obstruction 12. history cystic fibrosis 13. clinically evident bronchiectasis 14. history significant alcohol drug abuse 15. history thoracotomy pulmonary resection 16. oral patch ßadrenergics 17. oral corticosteroid medication unstable dose 18. regular use daytime oxygen therapy one hour per day 19 . Pulmonary rehabilitation program six week prior screen visit 20 . Investigational drug within one month six half life ( whichever great ) prior screen visit 21 . Known hypersensitivity ßadrenergic drug , BAC , EDTA 22 . Pregnant nursing woman 23 . Women childbearing potential use highly effective method birth control 24 . Patients previously randomise study currently participate another study 25 . Patients unable comply pulmonary medication restriction prior randomisation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>